{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:57:51Z","timestamp":1789077471691,"version":"build-2803163510"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"national cancer institute","doi-asserted-by":"publisher","award":["R21 CA226579"],"award-info":[{"award-number":["R21 CA226579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011306","name":"american society for investigative pathology","doi-asserted-by":"publisher","award":["2020 ASIP Summer Research Opportunity Program in Pathology"],"award-info":[{"award-number":["2020 ASIP Summer Research Opportunity Program in Pathology"]}],"id":[{"id":"10.13039\/100011306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer with an overall 5-year survival rate of less than 10%. The 1-year survival rate of patients with locally advanced or metastatic disease is abysmal. The aggressive nature of cancer cells, hypovascularization, extensive desmoplastic stroma, and immunosuppressive tumor microenvironment (TME) endows PDAC tumors with multiple mechanisms of drug resistance. With no obvious genetic mutation(s) driving tumor progression or metastatic transition, the challenges for understanding the biological mechanism(s) of these processes are paramount. A better understanding of the molecular and cellular mechanisms of these processes could lead to new diagnostic tools for patient management and new targets for therapeutic intervention. microRNAs (miRNAs) are an evolutionarily conserved gene class of short non-coding regulatory RNAs. miRNAs are an extensive regulatory layer that controls gene expression at the posttranscriptional level. This review focuses on preclinical models that functionally dissect miRNA activity in tumor progression or metastatic processes in PDAC. Collectively, these studies suggest an influence of miRNAs and RNA-RNA networks in the processes of epithelial to mesenchymal cell transition and cancer cell stemness. At a cell-type level, some miRNAs mainly influence cancer cell\u2013intrinsic processes and pathways, whereas other miRNAs predominantly act in distinct cellular compartments of the TME to regulate fibroblast and immune cell functions and\/or influence other cell types\u2019 function via cell-to-cell communications by transfer of extracellular vesicles. At a molecular level, the influence of miRNA-mediated regulation often converges in core signaling pathways, including TGF-\u03b2, JAK\/STAT, PI3K\/AKT, and NF-\u03baB.<\/jats:p>","DOI":"10.1007\/s10555-021-09995-x","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T07:03:30Z","timestamp":1632985410000},"page":"761-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-0122","authenticated-orcid":false,"given":"Lorenzo F.","family":"Sempere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schmittgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"9995_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7\u201333.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"9995_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020). Pancreatic cancer. Lancet, 395, 2008\u20132020.","journal-title":"Lancet"},{"key":"9995_CR3","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., & Neoptolemos, J. P. (2016). Pancreatic cancer. Nat Rev Dis Primers, 2, 16022.","journal-title":"Nat Rev Dis Primers"},{"key":"9995_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/gutjnl-2018-316822","volume":"68","author":"JR Conway","year":"2019","unstructured":"Conway, J. R., Herrmann, D., Evans, T. J., Morton, J. P., & Timpson, P. (2019). Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine. Gut, 68, 742\u2013758.","journal-title":"Gut"},{"key":"9995_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajpath.2018.09.009","volume":"189","author":"KJ Lafaro","year":"2019","unstructured":"Lafaro, K. J., & Melstrom, L. G. (2019). The paradoxical web of pancreatic cancer tumor microenvironment. American Journal of Pathology, 189, 44\u201357.","journal-title":"American Journal of Pathology"},{"key":"9995_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson, E. A., Bailey, P., Chang, D. K., & Biankin, A. V. (2019). Molecular subtypes of pancreatic cancer. Nature Reviews. Gastroenterology & Hepatology, 16, 207\u2013220.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"9995_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","volume":"26","author":"B Bockorny","year":"2020","unstructured":"Bockorny, B., Semenisty, V., Macarulla, T., Borazanci, E., Wolpin, B. M., Stemmer, S. M., Golan, T., Geva, R., Borad, M. J., Pedersen, K. S., Park, J. O., Ramirez, R. A., Abad, D. G., Feliu, J., Munoz, A., Ponz-Sarvise, M., Peled, A., Lustig, T. M., Bohana-Kashtan, O., et al. (2020). BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: The COMBAT trial. Nature Medicine, 26, 878\u2013885.","journal-title":"Nature Medicine"},{"key":"9995_CR8","doi-asserted-by":"crossref","unstructured":"Picozzi, V., Alseidi, A., Winter, J., Pishvaian, M., Mody, K., Glaspy, J., Larson, T., Matrana, M., Carney, M., Porter, S., Kouchakji, E., Rocha, F., and Carrier, E. (2020). Gemcitabine\/nab-paclitaxel with pamrevlumab: A novel drug combination and trial design for the treatment of locally advanced pancreatic cancer. ESMO Open 5.","DOI":"10.1136\/esmoopen-2019-000668"},{"key":"9995_CR9","doi-asserted-by":"crossref","unstructured":"Yang, J., Xu, R., Wang, C., Qiu, J., Ren, B., and You, L. (2021). Early screening and diagnosis strategies of pancreatic cancer: A comprehensive review. Cancer Commun (Lond).","DOI":"10.1002\/cac2.12204"},{"key":"9995_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neo.2021.06.005","volume":"23","author":"KE Affolter","year":"2021","unstructured":"Affolter, K. E., Hellwig, S., Nix, D. A., Bronner, M. P., Thomas, A., Fuertes, C. L., Hamil, C. L., Garrido-Laguna, I., Scaife, C. L., Mulvihill, S. J., & Underhill, H. R. (2021). Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia, 23, 859\u2013869.","journal-title":"Neoplasia"},{"key":"9995_CR11","doi-asserted-by":"publisher","first-page":"682872","DOI":"10.3389\/fonc.2021.682872","volume":"11","author":"K Miyabayashi","year":"2021","unstructured":"Miyabayashi, K., Nakagawa, H., & Koike, K. (2021). Molecular and phenotypic profiling for precision medicine in pancreatic cancer: Current advances and future perspectives. Front Oncol, 11, 682872.","journal-title":"Front Oncol"},{"key":"9995_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.cell.2015.04.048","volume":"161","author":"MC Whittle","year":"2015","unstructured":"Whittle, M. C., Izeradjene, K., Rani, P. G., Feng, L., Carlson, M. A., DelGiorno, K. E., Wood, L. D., Goggins, M., Hruban, R. H., Chang, A. E., Calses, P., Thorsen, S. M., & Hingorani, S. R. (2015). RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell, 161, 1345\u20131360.","journal-title":"Cell"},{"key":"9995_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., Hong, S. M., Fu, B., Lin, M. T., Calhoun, E. S., Kamiyama, M., Walter, K., Nikolskaya, T., Nikolsky, Y., Hartigan, J., et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801\u20131806.","journal-title":"Science"},{"key":"9995_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature25459","volume":"554","author":"S Mueller","year":"2018","unstructured":"Mueller, S., Engleitner, T., Maresch, R., Zukowska, M., Lange, S., Kaltenbacher, T., Konukiewitz, B., Ollinger, R., Zwiebel, M., Strong, A., Yen, H. Y., Banerjee, R., Louzada, S., Fu, B., Seidler, B., Gotzfried, J., Schuck, K., Hassan, Z., Arbeiter, A., et al. (2018). Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature, 554, 62\u201368.","journal-title":"Nature"},{"key":"9995_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ccell.2019.12.012","volume":"37","author":"EC Cheung","year":"2020","unstructured":"Cheung, E. C., DeNicola, G. M., Nixon, C., Blyth, K., Labuschagne, C. F., Tuveson, D. A., & Vousden, K. H. (2020). Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer. Cancer Cell, 37, 168-182 e164.","journal-title":"Cancer Cell"},{"key":"9995_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel, D. P. (2018). Metazoan MicroRNAs. Cell, 173, 20\u201351.","journal-title":"Cell"},{"key":"9995_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert, L. F. R., & MacRae, I. J. (2019). Regulation of microRNA function in animals. Nature Reviews Molecular Cell Biology, 20, 21\u201337.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"9995_CR18","doi-asserted-by":"crossref","unstructured":"Sempere, L.F., Azmi, A.S., and Moore, A. (2021). microRNA-based diagnostic and therapeutic applications in cancer medicine. Wiley Interdiscip Rev RNA, e1662.","DOI":"10.1002\/wrna.1662"},{"key":"9995_CR19","doi-asserted-by":"publisher","first-page":"174006","DOI":"10.1016\/j.ejphar.2021.174006","volume":"901","author":"Z Lotfi","year":"2021","unstructured":"Lotfi, Z., Najjary, S., Lotfi, F., Amini, M., Baghbanzadeh, A., Rashid, D. J., Asl, E. R., Baradaran, B., & Mokhtarzadeh, A. (2021). Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma. Eur J Pharmacol, 901, 174006.","journal-title":"Eur J Pharmacol"},{"key":"9995_CR20","doi-asserted-by":"crossref","unstructured":"Rawat, M., Kadian, K., Gupta, Y., Kumar, A., Chain, P.S.G., Kovbasnjuk, O., Kumar, S., and Parasher, G. (2019). MicroRNA in pancreatic cancer: From biology to therapeutic potential. Genes (Basel) 10.","DOI":"10.3390\/genes10100752"},{"key":"9995_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajpath.2018.10.005","volume":"189","author":"AA Tesfaye","year":"2019","unstructured":"Tesfaye, A. A., Azmi, A. S., & Philip, P. A. (2019). miRNA and gene expression in pancreatic ductal adenocarcinoma. American Journal of Pathology, 189, 58\u201370.","journal-title":"American Journal of Pathology"},{"key":"9995_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.21873\/cgp.20149","volume":"16","author":"UH Weidle","year":"2019","unstructured":"Weidle, U. H., Birzele, F., & Nopora, A. (2019). Pancreatic ductal adenocarcinoma: MicroRNAs affecting tumor growth and metastasis in preclinical in vivo models. Cancer Genomics & Proteomics, 16, 451\u2013464.","journal-title":"Cancer Genomics & Proteomics"},{"key":"9995_CR23","doi-asserted-by":"crossref","unstructured":"Uddin, M.H., Al-Hallak, M.N., Philip, P.A., Mohammad, R.M., Viola, N., Wagner, K.U., and Azmi, A.S. (2021). Exosomal microRNA in pancreatic cancer diagnosis, prognosis, and treatment: From bench to bedside. Cancers (Basel) 13.","DOI":"10.3390\/cancers13112777"},{"key":"9995_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-genet-120213-092023","volume":"49","author":"B Fromm","year":"2015","unstructured":"Fromm, B., Billipp, T., Peck, L. E., Johansen, M., Tarver, J. E., King, B. L., Newcomb, J. M., Sempere, L. F., Flatmark, K., Hovig, E., & Peterson, K. J. (2015). A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human micrornAome. Annual Review of Genetics, 49, 213\u2013242.","journal-title":"Annual Review of Genetics"},{"key":"9995_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson, D. W., & Dinger, M. E. (2016). Endogenous microRNA sponges: Evidence and controversy. Nature Reviews Genetics, 17, 272\u2013283.","journal-title":"Nature Reviews Genetics"},{"key":"9995_CR26","doi-asserted-by":"crossref","unstructured":"Rodriguez-Aznar, E., Wiesmuller, L., Sainz, B., Jr., and Hermann, P.C. (2019). EMT and stemness-key players in pancreatic cancer stem cells. Cancers (Basel) 11.","DOI":"10.3390\/cancers11081136"},{"key":"9995_CR27","doi-asserted-by":"publisher","first-page":"9163","DOI":"10.1007\/s13277-014-2185-5","volume":"35","author":"C Ma","year":"2014","unstructured":"Ma, C., Nong, K., Zhu, H., Wang, W., Huang, X., Yuan, Z., & Ai, K. (2014). H19 promotes pancreatic cancer metastasis by derepressing let-7\u2019s suppression on its target HMGA2-mediated EMT. Tumour Biology, 35, 9163\u20139169.","journal-title":"Tumour Biology"},{"key":"9995_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1541-7786.MCR-16-0327","volume":"15","author":"HR Mody","year":"2017","unstructured":"Mody, H. R., Hung, S. W., Pathak, R. K., Griffin, J., Cruz-Monserrate, Z., & Govindarajan, R. (2017). miR-202 diminishes TGFbeta receptors and attenuates TGFbeta1-induced EMT in pancreatic cancer. Molecular Cancer Research, 15, 1029\u20131039.","journal-title":"Molecular Cancer Research"},{"key":"9995_CR29","doi-asserted-by":"publisher","first-page":"14912","DOI":"10.18632\/oncotarget.7482","volume":"7","author":"C Wang","year":"2016","unstructured":"Wang, C., Liu, P., Wu, H., Cui, P., Li, Y., Liu, Y., Liu, Z., & Gou, S. (2016). MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Oncotarget, 7, 14912\u201314924.","journal-title":"Oncotarget"},{"key":"9995_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/1541-7786.MCR-16-0083","volume":"14","author":"HR Mody","year":"2016","unstructured":"Mody, H. R., Hung, S. W., AlSaggar, M., Griffin, J., & Govindarajan, R. (2016). Inhibition of S-adenosylmethionine-dependent methyltransferase attenuates TGFbeta1-induced EMT and metastasis in pancreatic cancer: Putative roles of miR-663a and miR-4787-5p. Molecular Cancer Research, 14, 1124\u20131135.","journal-title":"Molecular Cancer Research"},{"key":"9995_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/bjc.2015.102","volume":"112","author":"Z Zhu","year":"2015","unstructured":"Zhu, Z., Xu, Y., Zhao, J., Liu, Q., Feng, W., Fan, J., & Wang, P. (2015). miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-beta signalling pathway. British Journal of Cancer, 112, 1367\u20131375.","journal-title":"British Journal of Cancer"},{"key":"9995_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/carcin\/bgz121","volume":"41","author":"H Hu","year":"2020","unstructured":"Hu, H., Zhang, Q., Chen, W., Wu, T., Liu, S., Li, X., Luo, B., Zhang, T., Yan, G., Lu, H., & Lu, Z. (2020). MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK\/STAT3 signaling pathway by targeting SOCS5. Carcinogenesis, 41, 502\u2013514.","journal-title":"Carcinogenesis"},{"key":"9995_CR33","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3748\/wjg.v26.i19.2349","volume":"26","author":"KD Zhang","year":"2020","unstructured":"Zhang, K. D., Hu, B., Cen, G., Yang, Y. H., Chen, W. W., Guo, Z. Y., Wang, X. F., Zhao, Q., & Qiu, Z. J. (2020). MiR-301a transcriptionally activated by HIF-2alpha promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer. World Journal of Gastroenterology, 26, 2349\u20132373.","journal-title":"World Journal of Gastroenterology"},{"key":"9995_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.omtn.2019.06.015","volume":"17","author":"ZV Diaz-Riascos","year":"2019","unstructured":"Diaz-Riascos, Z. V., Ginesta, M. M., Fabregat, J., Serrano, T., Busquets, J., Buscail, L., Cordelier, P., & Capella, G. (2019). Expression and role of MicroRNAs from the miR-200 family in the tumor formation and metastatic propensity of pancreatic cancer. Mol Ther Nucleic Acids, 17, 491\u2013503.","journal-title":"Mol Ther Nucleic Acids"},{"key":"9995_CR35","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41388-018-0237-9","volume":"37","author":"Z Li","year":"2018","unstructured":"Li, Z., Jiang, P., Li, J., Peng, M., Zhao, X., Zhang, X., Chen, K., Zhang, Y., Liu, H., Gan, L., Bi, H., Zhen, P., Zhu, J., & Li, X. (2018). Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene, 37, 3822\u20133838.","journal-title":"Oncogene"},{"key":"9995_CR36","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1186\/s12885-018-4954-9","volume":"18","author":"M Zhuo","year":"2018","unstructured":"Zhuo, M., Yuan, C., Han, T., Cui, J., Jiao, F., & Wang, L. (2018). A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis. BMC Cancer, 18, 1032.","journal-title":"BMC Cancer"},{"key":"9995_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-13-0296","volume":"12","author":"G Zhao","year":"2013","unstructured":"Zhao, G., Wang, B., Liu, Y., Zhang, J. G., Deng, S. C., Qin, Q., Tian, K., Li, X., Zhu, S., Niu, Y., Gong, Q., & Wang, C. Y. (2013). miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Molecular Cancer Therapeutics, 12, 2569\u20132580.","journal-title":"Molecular Cancer Therapeutics"},{"key":"9995_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13046-018-0848-6","volume":"37","author":"Y Pan","year":"2018","unstructured":"Pan, Y., Lu, F., Xiong, P., Pan, M., Zhang, Z., Lin, X., Pan, M., & Huang, H. (2018). WIPF1 antagonizes the tumor suppressive effect of miR-141\/200c and is associated with poor survival in patients with PDAC. Journal of Experimental & Clinical Cancer Research, 37, 167.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9995_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2019.02.031","volume":"449","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Li, J., Guo, H., Wang, F., Ma, L., Du, C., Wang, Y., Wang, Q., Kornmann, M., Tian, X., & Yang, Y. (2019). BRM transcriptionally regulates miR-302a-3p to target SOCS5\/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Cancer Letters, 449, 215\u2013225.","journal-title":"Cancer Letters"},{"key":"9995_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/or.2017.5781","volume":"38","author":"DL Yu","year":"2017","unstructured":"Yu, D. L., Zhang, T., Wu, K., Li, Y., Wang, J., Chen, J., Li, X. Q., Peng, X. G., Wang, J. N., & Tan, L. G. (2017). MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1\/STAT3 pathway. Oncology Reports, 38, 1075\u20131082.","journal-title":"Oncology Reports"},{"key":"9995_CR41","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.7150\/jca.25006","volume":"9","author":"Y Xiong","year":"2018","unstructured":"Xiong, Y., Wang, Y., Wang, L., Huang, Y., Xu, Y., Xu, L., Guo, Y., Lu, J., Li, X., Zhu, M., & Qian, H. (2018). MicroRNA-30b targets snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. Journal of Cancer, 9, 2147\u20132159.","journal-title":"Journal of Cancer"},{"key":"9995_CR42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.yexcr.2017.10.033","volume":"361","author":"J Xiong","year":"2017","unstructured":"Xiong, J., Wang, D., Wei, A., Lu, H., Tan, C., Li, A., Tang, J., Wang, Y., He, S., Liu, X., & Hu, W. (2017). Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K\/Akt signaling via caveolin-1 and PTEN. Experimental Cell Research, 361, 316\u2013323.","journal-title":"Experimental Cell Research"},{"key":"9995_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41419-018-0839-8","volume":"9","author":"J Hu","year":"2018","unstructured":"Hu, J., Li, L., Chen, H., Zhang, G., Liu, H., Kong, R., Chen, H., Wang, Y., Li, Y., Tian, F., Lv, X., Li, G., & Sun, B. (2018). MiR-361-3p regulates ERK1\/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Cell Death & Disease, 9, 807.","journal-title":"Cell Death & Disease"},{"key":"9995_CR44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41419-021-03938-8","volume":"12","author":"G Ma","year":"2021","unstructured":"Ma, G., Li, G., Fan, W., Xu, Y., Song, S., Guo, K., & Liu, Z. (2021). Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression. Cell Death & Disease, 12, 656.","journal-title":"Cell Death & Disease"},{"key":"9995_CR45","first-page":"868","volume":"41","author":"J Ma","year":"2018","unstructured":"Ma, J., Zhang, J., Weng, Y. C., & Wang, J. C. (2018). EZH2-mediated microRNA-139-5p regulates epithelial-mesenchymal transition and lymph node metastasis of pancreatic cancer. Molecules and Cells, 41, 868\u2013880.","journal-title":"Molecules and Cells"},{"key":"9995_CR46","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1002\/jcb.29716","volume":"121","author":"C Wang","year":"2020","unstructured":"Wang, C., Yin, W., & Liu, H. (2020). MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition. Journal of Cellular Biochemistry, 121, 4505\u20134521.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9995_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","volume":"49","author":"F Kai","year":"2019","unstructured":"Kai, F., Drain, A. P., & Weaver, V. M. (2019). The extracellular matrix modulates the metastatic journey. Developmental Cell, 49, 332\u2013346.","journal-title":"Developmental Cell"},{"key":"9995_CR48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/carcin\/bgv027","volume":"36","author":"Y Zou","year":"2015","unstructured":"Zou, Y., Li, J., Chen, Z., Li, X., Zheng, S., Yi, D., Zhong, A., & Chen, J. (2015). miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients. Carcinogenesis, 36, 676\u2013684.","journal-title":"Carcinogenesis"},{"key":"9995_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-16-1898","volume":"77","author":"P Yuan","year":"2017","unstructured":"Yuan, P., He, X. H., Rong, Y. F., Cao, J., Li, Y., Hu, Y. P., Liu, Y., Li, D., Lou, W., & Liu, M. F. (2017). KRAS\/NF-kappaB\/YY1\/miR-489 signaling axis controls pancreatic cancer metastasis. Cancer Research, 77, 100\u2013111.","journal-title":"Cancer Research"},{"key":"9995_CR50","first-page":"139","volume":"7","author":"Y Fan","year":"2017","unstructured":"Fan, Y., Shi, C., Li, T., & Kuang, T. (2017). microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6. American Journal of Cancer Research, 7, 139\u2013147.","journal-title":"American Journal of Cancer Research"},{"key":"9995_CR51","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13046-018-0807-2","volume":"37","author":"Y Fu","year":"2018","unstructured":"Fu, Y., Liu, X., Chen, Q., Liu, T., Lu, C., Yu, J., Miao, Y., & Wei, J. (2018). Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Journal of Experimental & Clinical Cancer Research, 37, 130.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9995_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2020.02.033","volume":"477","author":"D Zhu","year":"2020","unstructured":"Zhu, D., Zheng, S., Fang, C., Guo, X., Han, D., Tang, M., Fu, H., Jiang, M., Xie, N., Nie, Y., Yao, X., & Chen, Y. (2020). Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-kappaB\/MDM2 via miR-342-3p. Cancer Letters, 477, 107\u2013121.","journal-title":"Cancer Letters"},{"key":"9995_CR53","first-page":"1884","volume":"54","author":"Q Wang","year":"2019","unstructured":"Wang, Q., Wang, J., Niu, S., Wang, S., Liu, Y., & Wang, X. (2019). MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma. International Journal of Oncology, 54, 1884\u20131896.","journal-title":"International Journal of Oncology"},{"key":"9995_CR54","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","volume":"80","author":"CH Wong","year":"2020","unstructured":"Wong, C. H., Lou, U. K., Li, Y., Chan, S. L., Tong, J. H., To, K. F., & Chen, Y. (2020). CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942. Cancer Research, 80, 2138\u20132149.","journal-title":"Cancer Research"},{"key":"9995_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-020-00360-5","volume":"6","author":"W Liu","year":"2020","unstructured":"Liu, W., Tang, J., Zhang, H., Kong, F., Zhu, H., Li, P., Li, Z., Kong, X., & Wang, K. (2020). A novel lncRNA PTTG3P\/miR-132\/212-3p\/FoxM1 feedback loop facilitates tumorigenesis and metastasis of pancreatic cancer. Cell Death Discov, 6, 136.","journal-title":"Cell Death Discov"},{"key":"9995_CR56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2014.04.048","volume":"147","author":"L Li","year":"2014","unstructured":"Li, L., Li, Z., Kong, X., Xie, D., Jia, Z., Jiang, W., Cui, J., Du, Y., Wei, D., Huang, S., & Xie, K. (2014). Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and beta-catenin signaling in pancreatic ductal adenocarcinoma cells. Gastroenterology, 147, 485-497 e418.","journal-title":"Gastroenterology"},{"key":"9995_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10142-016-0512-1","volume":"17","author":"AC Azevedo-Pouly","year":"2017","unstructured":"Azevedo-Pouly, A. C., Sutaria, D. S., Jiang, J., Elgamal, O. A., Amari, F., Allard, D., Grippo, P. J., Coppola, V., & Schmittgen, T. D. (2017). miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216\/miR-217 host gene is embryonic lethal. Functional & Integrative Genomics, 17, 203\u2013212.","journal-title":"Functional & Integrative Genomics"},{"key":"9995_CR58","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s41598-017-05274-4","volume":"7","author":"P Liu","year":"2017","unstructured":"Liu, P., Yang, H., Zhang, J., Peng, X., Lu, Z., Tong, W., & Chen, J. (2017). The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Science and Reports, 7, 5186.","journal-title":"Science and Reports"},{"key":"9995_CR59","doi-asserted-by":"publisher","first-page":"11147","DOI":"10.1038\/s41598-019-47566-x","volume":"9","author":"DS Sutaria","year":"2019","unstructured":"Sutaria, D. S., Jiang, J., Azevedo-Pouly, A. C., Wright, L., Bray, J. A., Fredenburg, K., Liu, X., Lu, J., Torres, C., Mancinelli, G., Grippo, P. J., Coppola, V., & Schmittgen, T. D. (2019). Knockout of acinar enriched microRNAs in mice promote duct formation but not pancreatic cancer. Science and Reports, 9, 11147.","journal-title":"Science and Reports"},{"key":"9995_CR60","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/carcin\/bgq160","volume":"31","author":"WG Zhao","year":"2010","unstructured":"Zhao, W. G., Yu, S. N., Lu, Z. H., Ma, Y. H., Gu, Y. M., & Chen, J. (2010). The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis, 31, 1726\u20131733.","journal-title":"Carcinogenesis"},{"key":"9995_CR61","doi-asserted-by":"publisher","first-page":"581694","DOI":"10.3389\/fgene.2021.581694","volume":"12","author":"B Wang","year":"2021","unstructured":"Wang, B., Xu, Y., Wei, Y., Lv, L., Liu, N., Lin, R., Wang, X., & Shi, B. (2021). Human mesenchymal stem cell-derived exosomal microRNA-143 promotes apoptosis and suppresses cell growth in pancreatic cancer via target gene regulation. Front Genet, 12, 581694.","journal-title":"Front Genet"},{"key":"9995_CR62","doi-asserted-by":"publisher","first-page":"109424","DOI":"10.1016\/j.biopha.2019.109424","volume":"119","author":"F Xie","year":"2019","unstructured":"Xie, F., Li, C., Zhang, X., Peng, W., & Wen, T. (2019). MiR-143\u20133p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Biomed Pharmacother, 119, 109424.","journal-title":"Biomed Pharmacother"},{"key":"9995_CR63","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s13277-012-0446-8","volume":"33","author":"Y Hu","year":"2012","unstructured":"Hu, Y., Ou, Y., Wu, K., Chen, Y., & Sun, W. (2012). miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Tumour Biology, 33, 1863\u20131870.","journal-title":"Tumour Biology"},{"key":"9995_CR64","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41467-020-17150-3","volume":"11","author":"JW Franses","year":"2020","unstructured":"Franses, J. W., Philipp, J., Missios, P., Bhan, I., Liu, A., Yashaswini, C., Tai, E., Zhu, H., Ligorio, M., Nicholson, B., Tassoni, E. M., Desai, N., Kulkarni, A. S., Szabolcs, A., Hong, T. S., Liss, A. S., Fernandez-Del Castillo, C., Ryan, D. P., Maheswaran, S., et al. (2020). Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target. Nature Communications, 11, 3303.","journal-title":"Nature Communications"},{"key":"9995_CR65","doi-asserted-by":"publisher","first-page":"60414","DOI":"10.18632\/oncotarget.19578","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Li, J., Guo, S., Ouyang, Y., Yin, L., Liu, S., Zhao, Z., Yang, J., Huang, W., Qin, H., Zhao, X., Ni, B., & Wang, H. (2017). Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Oncotarget, 8, 60414\u201360428.","journal-title":"Oncotarget"},{"key":"9995_CR66","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello, L., Guo, C. J., Chen, L. L., & Huarte, M. (2021). Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology, 22, 96\u2013118.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"9995_CR67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41571-018-0035-x","volume":"15","author":"S Anfossi","year":"2018","unstructured":"Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018). Clinical utility of circulating non-coding RNAs - An update. Nature Reviews. Clinical Oncology, 15, 541\u2013563.","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"9995_CR68","unstructured":"Machiela, E., Popkie, A., and Sempere, L. (2015). Individual noncoding RNA variations: Their role in shaping and maintaining the epigenetic landscape. In Personalized Epigenetics, Trygve Tollefsbol, ed. Waltham, Massachusetts: Academic Press, 2015, Chapter 4 pages: 84\u2013114. ISBN-13: 978\u20130124201354."},{"key":"9995_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen, L. S., Andersen, M. S., Stagsted, L. V. W., Ebbesen, K. K., Hansen, T. B., & Kjems, J. (2019). The biogenesis, biology and characterization of circular RNAs. Nature Reviews Genetics, 20, 675\u2013691.","journal-title":"Nature Reviews Genetics"},{"key":"9995_CR70","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jcmm.13351","volume":"22","author":"X Zhao","year":"2018","unstructured":"Zhao, X., Liu, Y., Li, Z., Zheng, S., Wang, Z., Li, W., Bi, Z., Li, L., Jiang, Y., Luo, Y., Lin, Q., Fu, Z., & Rufu, C. (2018). Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine, 22, 655\u2013667.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9995_CR71","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/jcp.27039","volume":"234","author":"Z Luo","year":"2019","unstructured":"Luo, Z., Yi, Z. J., Ou, Z. L., Han, T., Wan, T., Tang, Y. C., Wang, Z. C., & Huang, F. Z. (2019). RELA\/NEAT1\/miR-302a-3p\/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Journal of Cellular Physiology, 234, 3583\u20133597.","journal-title":"Journal of Cellular Physiology"},{"key":"9995_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2019.05.021","volume":"113","author":"J Shen","year":"2019","unstructured":"Shen, J., Hong, L., Yu, D., Cao, T., Zhou, Z., & He, S. (2019). LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression. International Journal of Biochemistry & Cell Biology, 113, 17\u201326.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"9995_CR73","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Ma, H., and Chen, C. (2021). Long noncoding RNA PCED1BAS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR4113p\/HIF1alpha axis. Oncol Rep 46.","DOI":"10.3892\/or.2021.8085"},{"key":"9995_CR74","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/15384047.2018.1529121","volume":"20","author":"Y Sun","year":"2019","unstructured":"Sun, Y., Wang, P., Yang, W., Shan, Y., Zhang, Q., & Wu, H. (2019). The role of lncRNA MSC-AS1\/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis. Cancer Biology & Therapy, 20, 729\u2013739.","journal-title":"Cancer Biology & Therapy"},{"key":"9995_CR75","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1002\/jcb.27669","volume":"120","author":"Y Sun","year":"2019","unstructured":"Sun, Y., Zhu, Q., Yang, W., Shan, Y., Yu, Z., Zhang, Q., & Wu, H. (2019). LncRNA H19\/miR-194\/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. Journal of Cellular Biochemistry, 120, 3874\u20133886.","journal-title":"Journal of Cellular Biochemistry"},{"key":"9995_CR76","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13046-019-1436-0","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Li, Z., Zhang, M., Wang, B., Ye, J., Zhang, Y., Tang, D., Ma, D., Jin, W., Li, X., & Wang, S. (2019). Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research, 38, 466.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9995_CR77","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2147\/OTT.S286666","volume":"14","author":"S Deng","year":"2021","unstructured":"Deng, S., Wang, J., Zhang, L., Li, J., & Jin, Y. (2021). LncRNA HOTAIR promotes cancer stem-like cells properties by sponging miR-34a to activate the JAK2\/STAT3 pathway in pancreatic ductal adenocarcinoma. Oncotargets and Therapy, 14, 1883\u20131893.","journal-title":"Oncotargets and Therapy"},{"key":"9995_CR78","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/15384101.2020.1731645","volume":"19","author":"S Bi","year":"2020","unstructured":"Bi, S., Wang, Y., Feng, H., & Li, Q. (2020). Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expression. Cell Cycle, 19, 801\u2013816.","journal-title":"Cell Cycle"},{"key":"9995_CR79","doi-asserted-by":"publisher","first-page":"640587","DOI":"10.3389\/fcell.2021.640587","volume":"9","author":"WJ Li","year":"2021","unstructured":"Li, W. J., Wang, Y., Liu, R., Kasinski, A. L., Shen, H., Slack, F. J., & Tang, D. G. (2021). MicroRNA-34a: potent tumor suppressor, cancer stem cell inhibitor, and potential anticancer therapeutic. Front Cell Dev Biol, 9, 640587.","journal-title":"Front Cell Dev Biol"},{"key":"9995_CR80","first-page":"6857042","volume":"2018","author":"Y Lu","year":"2018","unstructured":"Lu, Y., Tang, L., Zhang, Z., Li, S., Liang, S., Ji, L., Yang, B., Liu, Y., & Wei, W. (2018). Long noncoding RNA TUG1\/miR-29c axis affects cell proliferation, invasion, and migration in human pancreatic cancer. Disease Markers, 2018, 6857042.","journal-title":"Disease Markers"},{"key":"9995_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MPA.0000000000001751","volume":"50","author":"JR Li","year":"2021","unstructured":"Li, J. R., Liu, L., Luo, H., Chen, Z. G., Wang, J. H., & Li, N. F. (2021). Long noncoding RNA DUXAP8 promotes pancreatic carcinoma cell migration and invasion via pathway by miR-448\/WTAP\/Fak signaling axis. Pancreas, 50, 317\u2013326.","journal-title":"Pancreas"},{"key":"9995_CR82","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-019-0777-7","volume":"12","author":"G Xiong","year":"2019","unstructured":"Xiong, G., Liu, C., Yang, G., Feng, M., Xu, J., Zhao, F., You, L., Zhou, L., Zheng, L., Hu, Y., Wang, X., Zhang, T., & Zhao, Y. (2019). Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer. Journal of Hematology & Oncology, 12, 97.","journal-title":"Journal of Hematology & Oncology"},{"key":"9995_CR83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/0008-5472.CAN-20-0256","volume":"81","author":"Y Geng","year":"2021","unstructured":"Geng, Y., Fan, J., Chen, L., Zhang, C., Qu, C., Qian, L., Chen, K., Meng, Z., Chen, Z., & Wang, P. (2021). A Notch-dependent inflammatory feedback circuit between macrophages and cancer cells regulates pancreatic cancer metastasis. Cancer Research, 81, 64\u201376.","journal-title":"Cancer Research"},{"key":"9995_CR84","doi-asserted-by":"publisher","first-page":"22793","DOI":"10.1038\/srep22793","volume":"6","author":"Y Fan","year":"2016","unstructured":"Fan, Y., Xu, L. L., Shi, C. Y., Wei, W., Wang, D. S., & Cai, D. F. (2016). MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Science and Reports, 6, 22793.","journal-title":"Science and Reports"},{"key":"9995_CR85","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3389\/fimmu.2020.00890","volume":"11","author":"Q Xi","year":"2020","unstructured":"Xi, Q., Chen, Y., Yang, G. Z., Zhang, J. Y., Zhang, L. J., Guo, X. D., Zhao, J. Y., Xue, Z. Y., Li, Y., & Zhang, R. (2020). miR-128 regulates tumor cell CD47 expression and promotes anti-tumor immunity in pancreatic cancer. Frontiers in Immunology, 11, 890.","journal-title":"Frontiers in Immunology"},{"key":"9995_CR86","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/ijc.33041","volume":"147","author":"J Schipper","year":"2020","unstructured":"Schipper, J., Westerhuis, J. J., Beddows, I., Madaj, Z., Monsma, D., Hostetter, G., Kiupel, M., Conejo-Garcia, J. R., & Sempere, L. F. (2020). Loss of microRNA-21 leads to profound stromal remodeling and short survival in K-Ras-driven mouse models of pancreatic cancer. International Journal of Cancer, 147, 2265\u20132278.","journal-title":"International Journal of Cancer"},{"key":"9995_CR87","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3727\/096504017X14934840662335","volume":"26","author":"L Zhang","year":"2018","unstructured":"Zhang, L., Yao, J., Li, W., & Zhang, C. (2018). Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer. Oncology Research, 26, 827\u2013835.","journal-title":"Oncology Research"},{"key":"9995_CR88","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.1038\/srep11450","volume":"5","author":"JJ Kwon","year":"2015","unstructured":"Kwon, J. J., Nabinger, S. C., Vega, Z., Sahu, S. S., Alluri, R. K., Abdul-Sater, Z., Yu, Z., Gore, J., Nalepa, G., Saxena, R., Korc, M., & Kota, J. (2015). Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Science and Reports, 5, 11450.","journal-title":"Science and Reports"},{"key":"9995_CR89","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","volume":"20","author":"D Bautista-Sanchez","year":"2020","unstructured":"Bautista-Sanchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velazquez, I. A., Gonzalez-Barrios, R., Contreras-Espinosa, L., Montiel-Manriquez, R., Castro-Hernandez, C., Fragoso-Ontiveros, V., Alvarez-Gomez, R. M., & Herrera, L. A. (2020). The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther Nucleic Acids, 20, 409\u2013420.","journal-title":"Mol Ther Nucleic Acids"},{"key":"9995_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","volume":"6","author":"FJ Sheedy","year":"2015","unstructured":"Sheedy, F. J. (2015). Turning 21: Induction of miR-21 as a key switch in the inflammatory response. Frontiers in Immunology, 6, 19.","journal-title":"Frontiers in Immunology"},{"key":"9995_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G., & Tuveson, D. A. (2021). Diversity and biology of cancer-associated fibroblasts. Physiological Reviews, 101, 147\u2013176.","journal-title":"Physiological Reviews"},{"key":"9995_CR92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","volume":"10","author":"E Helms","year":"2020","unstructured":"Helms, E., Onate, M. K., & Sherman, M. H. (2020). Fibroblast heterogeneity in the pancreatic tumor microenvironment. Cancer Discovery, 10, 648\u2013656.","journal-title":"Cancer Discovery"},{"key":"9995_CR93","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D Ohlund","year":"2017","unstructured":"Ohlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I., Hwang, C. I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., et al. (2017). Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Journal of Experimental Medicine, 214, 579\u2013596.","journal-title":"Journal of Experimental Medicine"},{"key":"9995_CR94","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019). IL1-induced JAK\/STAT signaling is antagonized by TGFbeta to shape CAF Heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discovery, 9, 282\u2013301.","journal-title":"Cancer Discovery"},{"key":"9995_CR95","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., Sivajothi, S., Armstrong, T. D., Engle, D. D., Yu, K. H., Hao, Y., Wolfgang, C. L., Park, Y., Preall, J., Jaffee, E. M., et al. (2019). Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discovery, 9, 1102\u20131123.","journal-title":"Cancer Discovery"},{"key":"9995_CR96","doi-asserted-by":"crossref","unstructured":"Steele, N.G., Biffi, G., Kemp, S.B., Zhang, Y., Drouillard, D., Syu, L., Hao, Y., Oni, T.E., Brosnan, E., Elyada, E., Doshi, A., Hansma, C., Espinoza, C., Abbas, A., The, S., Irizarry-Negron, V., Halbrook, C.J., Franks, N.E., Hoffman, M.T., et al. (2021). Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer. Clin Cancer Res.","DOI":"10.1158\/1538-7445.AM2021-117"},{"key":"9995_CR97","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C. C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., De Jesus-Acosta, A., Sharma, P., Heidari, P., Mahmood, U., Chin, L., Moses, H. L., Weaver, V. M., Maitra, A., Allison, J. P., et al. (2014). Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell, 25, 719\u2013734.","journal-title":"Cancer Cell"},{"key":"9995_CR98","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., Westphalen, C. B., Kitajewski, J., Fernandez-Barrena, M. G., Fernandez-Zapico, M. E., Iacobuzio-Donahue, C., Olive, K. P., & Stanger, B. Z. (2014). Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell, 25, 735\u2013747.","journal-title":"Cancer Cell"},{"key":"9995_CR99","doi-asserted-by":"publisher","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","volume":"111","author":"JJ Lee","year":"2014","unstructured":"Lee, J. J., Perera, R. M., Wang, H., Wu, D. C., Liu, X. S., Han, S., Fitamant, J., Jones, P. D., Ghanta, K. S., Kawano, S., Nagle, J. M., Deshpande, V., Boucher, Y., Kato, T., Chen, J. K., Willmann, J. K., Bardeesy, N., & Beachy, P. A. (2014). Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci U S A, 111, E3091-3100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9995_CR100","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1158\/1078-0432.CCR-10-1152","volume":"16","author":"LF Sempere","year":"2010","unstructured":"Sempere, L. F., Preis, M., Yezefski, T., Ouyang, H., Suriawinata, A. A., Silahtaroglu, A., Conejo-Garcia, J. R., Kauppinen, S., Wells, W., & Korc, M. (2010). Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors. Clinical Cancer Research, 16, 4246\u20134255.","journal-title":"Clinical Cancer Research"},{"key":"9995_CR101","doi-asserted-by":"crossref","unstructured":"Preis, M., Gardner, T.B., Gordon, S.R., Pipas, M.J., Mackenzie, T.A., Klein, E.E., Longnecker, D.S., Gutmann, E.J., Sempere, L.F., and Korc, M. (2011). microRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin.Cancer Res.","DOI":"10.1158\/1078-0432.CCR-11-0695"},{"key":"9995_CR102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-62703-287-2_4","volume":"980","author":"LF Sempere","year":"2013","unstructured":"Sempere, L. F., & Korc, M. (2013). A method for conducting highly sensitive microRNA in situ hybridization and immunohistochemical analysis in pancreatic cancer. Methods in Molecular Biology, 980, 43\u201359.","journal-title":"Methods in Molecular Biology"},{"key":"9995_CR103","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-0716-0623-0_17","volume":"2148","author":"LF Sempere","year":"2020","unstructured":"Sempere, L. F., Zaluzec, E., Kenyon, E., Kiupel, M., & Moore, A. (2020). Automated five-color multiplex co-detection of Microrna and protein expression in fixed tissue specimens. Methods in Molecular Biology, 2148, 257\u2013276.","journal-title":"Methods in Molecular Biology"},{"key":"9995_CR104","doi-asserted-by":"publisher","first-page":"e71978","DOI":"10.1371\/journal.pone.0071978","volume":"8","author":"BE Kadera","year":"2013","unstructured":"Kadera, B. E., Li, L., Toste, P. A., Wu, N., Adams, C., Dawson, D. W., & Donahue, T. R. (2013). MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS ONE, 8, e71978.","journal-title":"PLoS ONE"},{"key":"9995_CR105","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jso.23750","volume":"110","author":"TR Donahue","year":"2014","unstructured":"Donahue, T. R., Nguyen, A. H., Moughan, J., Li, L., Tatishchev, S., Toste, P., & Farrell, J. J. (2014). Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer. Journal of Surgical Oncology, 110, 952\u2013959.","journal-title":"Journal of Surgical Oncology"},{"key":"9995_CR106","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.1021\/acs.analchem.5b03159","volume":"87","author":"E Ensink","year":"2015","unstructured":"Ensink, E., Sinha, J., Sinha, A., Tang, H., Calderone, H. M., Hostetter, G., Winter, J., Cherba, D., Brand, R. E., Allen, P. J., Sempere, L. F., & Haab, B. B. (2015). Segment and fit thresholding: A new method for image analysis applied to microarray and immunofluorescence data. Analytical Chemistry, 87, 9715\u20139721.","journal-title":"Analytical Chemistry"},{"key":"9995_CR107","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1373\/clinchem.2009.137364","volume":"56","author":"MC du Rieu","year":"2010","unstructured":"du Rieu, M. C., Torrisani, J., Selves, J., Al, S. T., Souque, A., Dufresne, M., Tsongalis, G. J., Suriawinata, A. A., Carrere, N., Buscail, L., & Cordelier, P. (2010). MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clinical Chemistry, 56, 603\u2013612.","journal-title":"Clinical Chemistry"},{"key":"9995_CR108","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7150\/ijbs.22555","volume":"14","author":"S Chen","year":"2018","unstructured":"Chen, S., Chen, X., Shan, T., Ma, J., Lin, W., Li, W., & Kang, Y. (2018). MiR-21-mediated metabolic alteration of cancer-associated fibroblasts and its effect on pancreatic cancer cell behavior. International Journal of Biological Sciences, 14, 100\u2013110.","journal-title":"International Journal of Biological Sciences"},{"key":"9995_CR109","doi-asserted-by":"crossref","unstructured":"Sempere, L.F., Keto, J., and Fabbri, M. (2017). Exosomal MicroRNAs in breast cancer towards diagnostic and therapeutic applications. Cancers (Basel) 9.","DOI":"10.3390\/cancers9070071"},{"key":"9995_CR110","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1172\/JCI81135","volume":"126","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. (2016). The biology and function of exosomes in cancer. The Journal of Clinical Investigation, 126, 1208\u20131215.","journal-title":"The Journal of Clinical Investigation"},{"key":"9995_CR111","doi-asserted-by":"crossref","unstructured":"Hussain, Z., Nigri, J., and Tomasini, R. (2021). The cellular and biological impact of extracellular vesicles in pancreatic cancer. Cancers (Basel) 13.","DOI":"10.3390\/cancers13123040"},{"key":"9995_CR112","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin-Smith, G. K., Ayre, D. C., Bach, J. M., Bachurski, D., Baharvand, H., Balaj, L., Baldacchino, S., Bauer, N. N., Baxter, A. A., Bebawy, M., et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 7, 1535750.","journal-title":"J Extracell Vesicles"},{"key":"9995_CR113","doi-asserted-by":"crossref","unstructured":"Pardini, B., and Calin, G.A. (2019). MicroRNAs and long non-coding RNAs and their hormone-like activities in cancer. Cancers (Basel) 11.","DOI":"10.3390\/cancers11030378"},{"key":"9995_CR114","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1159\/000495281","volume":"51","author":"Z Li","year":"2018","unstructured":"Li, Z., Tao, Y., Wang, X., Jiang, P., Li, J., Peng, M., Zhang, X., Chen, K., Liu, H., Zhen, P., Zhu, J., Liu, X., & Liu, X. (2018). Tumor-secreted exosomal miR-222 promotes tumor progression via regulating P27 Expression and re-localization in pancreatic cancer. Cellular Physiology and Biochemistry, 51, 610\u2013629.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"9995_CR115","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-020-01178-6","volume":"19","author":"MJ Jiang","year":"2020","unstructured":"Jiang, M. J., Chen, Y. Y., Dai, J. J., Gu, D. N., Mei, Z., Liu, F. R., Huang, Q., & Tian, L. (2020). Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. Molecular Cancer, 19, 68.","journal-title":"Molecular Cancer"},{"key":"9995_CR116","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-019-00476-6","volume":"43","author":"Z Yang","year":"2020","unstructured":"Yang, Z., Zhao, N., Cui, J., Wu, H., Xiong, J., & Peng, T. (2020). Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Cellular Oncology (Dordrecht), 43, 123\u2013136.","journal-title":"Cellular Oncology (Dordrecht)"},{"key":"9995_CR117","doi-asserted-by":"publisher","first-page":"42339","DOI":"10.1038\/srep42339","volume":"7","author":"M Mikamori","year":"2017","unstructured":"Mikamori, M., Yamada, D., Eguchi, H., Hasegawa, S., Kishimoto, T., Tomimaru, Y., Asaoka, T., Noda, T., Wada, H., Kawamoto, K., Gotoh, K., Takeda, Y., Tanemura, M., Mori, M., & Doki, Y. (2017). MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma. Science and Reports, 7, 42339.","journal-title":"Science and Reports"},{"key":"9995_CR118","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3389\/fimmu.2019.02819","volume":"10","author":"H Sun","year":"2019","unstructured":"Sun, H., Shi, K., Qi, K., Kong, H., Zhang, J., Dai, S., Ye, W., Deng, T., He, Q., & Zhou, M. (2019). Natural Killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26. Frontiers in Immunology, 10, 2819.","journal-title":"Frontiers in Immunology"},{"key":"9995_CR119","doi-asserted-by":"publisher","first-page":"111543","DOI":"10.1016\/j.yexcr.2019.111543","volume":"383","author":"Y Fang","year":"2019","unstructured":"Fang, Y., Zhou, W., Rong, Y., Kuang, T., Xu, X., Wu, W., Wang, D., & Lou, W. (2019). Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Exp Cell Res, 383, 111543.","journal-title":"Exp Cell Res"},{"key":"9995_CR120","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","volume":"78","author":"Y Binenbaum","year":"2018","unstructured":"Binenbaum, Y., Fridman, E., Yaari, Z., Milman, N., Schroeder, A., Ben David, G., Shlomi, T., & Gil, Z. (2018). Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma. Cancer Research, 78, 5287\u20135299.","journal-title":"Cancer Research"},{"key":"9995_CR121","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018). Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3Kgamma to promote pancreatic cancer metastasis. Cancer Research, 78, 4586\u20134598.","journal-title":"Cancer Research"},{"key":"9995_CR122","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13046-019-1313-x","volume":"38","author":"Z Yin","year":"2019","unstructured":"Yin, Z., Ma, T., Huang, B., Lin, L., Zhou, Y., Yan, J., Zou, Y., & Chen, S. (2019). Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-beta signaling pathway. Journal of Experimental & Clinical Cancer Research, 38, 310.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9995_CR123","doi-asserted-by":"crossref","unstructured":"Chang, J., Li, H., Zhu, Z., Mei, P., Hu, W., Xiong, X., and Tao, J. (2021). microRNA-21\u20135p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3. Cell Biol Toxicol.","DOI":"10.1007\/s10565-021-09597-x"},{"key":"9995_CR124","first-page":"1025","volume":"56","author":"Q Ma","year":"2020","unstructured":"Ma, Q., Wu, H., Xiao, Y., Liang, Z., & Liu, T. (2020). Upregulation of exosomal microRNA21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras\/ERK pathway activity. International Journal of Oncology, 56, 1025\u20131033.","journal-title":"International Journal of Oncology"},{"key":"9995_CR125","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2020.06.009","volume":"490","author":"M Li","year":"2020","unstructured":"Li, M., Guo, H., Wang, Q., Chen, K., Marko, K., Tian, X., & Yang, Y. (2020). Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K\/Akt pathway. Cancer Letters, 490, 20\u201330.","journal-title":"Cancer Letters"},{"key":"9995_CR126","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2018.04.035","volume":"432","author":"Z Li","year":"2018","unstructured":"Li, Z., Yanfang, W., Li, J., Jiang, P., Peng, T., Chen, K., Zhao, X., Zhang, Y., Zhen, P., Zhu, J., & Li, X. (2018). Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338\/MACC1\/MET pathway in pancreatic cancer. Cancer Letters, 432, 237\u2013250.","journal-title":"Cancer Letters"},{"key":"9995_CR127","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R., & Wood, M. J. A. (2020). Advances in oligonucleotide drug delivery. Nature Reviews. Drug Discovery, 19, 673\u2013694.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"9995_CR128","doi-asserted-by":"crossref","unstructured":"Forterre, A., Komuro, H., Aminova, S., and Harada, M. (2020). A comprehensive review of cancer MicroRNA therapeutic delivery strategies. Cancers (Basel) 12.","DOI":"10.3390\/cancers12071852"},{"key":"9995_CR129","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.18632\/oncotarget.27160","volume":"10","author":"ME Gilles","year":"2019","unstructured":"Gilles, M. E., Hao, L., Brown, K., Lim, J., Bhatia, S. N., & Slack, F. J. (2019). Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer. Oncotarget, 10, 5349\u20135358.","journal-title":"Oncotarget"},{"key":"9995_CR130","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-11-0152","volume":"10","author":"D Pramanik","year":"2011","unstructured":"Pramanik, D., Campbell, N. R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J. T., & Maitra, A. (2011). Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Molecular Cancer Therapeutics, 10, 1470\u20131480.","journal-title":"Molecular Cancer Therapeutics"},{"key":"9995_CR131","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong, D. S., Kang, Y. K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J. L., Kim, T. Y., Shin, S., Becerra, C. R., Falchook, G., Stoudemire, J., Martin, D., Kelnar, K., Peltier, H., Bonato, V., Bader, A. G., et al. (2020). Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. British Journal of Cancer, 122, 1630\u20131637.","journal-title":"British Journal of Cancer"},{"key":"9995_CR132","first-page":"2933","volume":"9","author":"S Arora","year":"2014","unstructured":"Arora, S., Swaminathan, S. K., Kirtane, A., Srivastava, S. K., Bhardwaj, A., Singh, S., Panyam, J., & Singh, A. P. (2014). Synthesis, characterization, and evaluation of poly (D, L-lactide-co-glycolide)-based nanoformulation of miRNA-150: Potential implications for pancreatic cancer therapy. International Journal of Nanomedicine, 9, 2933\u20132942.","journal-title":"International Journal of Nanomedicine"},{"key":"9995_CR133","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.canlet.2018.10.039","volume":"442","author":"Y Ding","year":"2019","unstructured":"Ding, Y., Cao, F., Sun, H., Wang, Y., Liu, S., Wu, Y., Cui, Q., Mei, W., & Li, F. (2019). Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Letters, 442, 351\u2013361.","journal-title":"Cancer Letters"},{"key":"9995_CR134","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017). Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 546, 498\u2013503.","journal-title":"Nature"},{"key":"9995_CR135","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1021\/acsnano.9b03978","volume":"14","author":"Y Xie","year":"2020","unstructured":"Xie, Y., Hang, Y., Wang, Y., Sleightholm, R., Prajapati, D. R., Bader, J., Yu, A., Tang, W., Jaramillo, L., Li, J., Singh, R. K., & Oupicky, D. (2020). Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA\/siRNA nanotherapy. ACS Nano, 14, 255\u2013271.","journal-title":"ACS Nano"},{"key":"9995_CR136","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1002\/cam4.2633","volume":"8","author":"S Shang","year":"2019","unstructured":"Shang, S., Wang, J., Chen, S., Tian, R., Zeng, H., Wang, L., Xia, M., Zhu, H., & Zuo, C. (2019). Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Cancer Medicine, 8, 7728\u20137740.","journal-title":"Cancer Medicine"},{"key":"9995_CR137","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.omtn.2019.02.022","volume":"16","author":"DM Wu","year":"2019","unstructured":"Wu, D. M., Wen, X., Han, X. R., Wang, S., Wang, Y. J., Shen, M., Fan, S. H., Zhang, Z. F., Shan, Q., Li, M. Q., Hu, B., Lu, J., Chen, G. Q., & Zheng, Y. L. (2019). Bone marrow mesenchymal stem cell-derived exosomal MicroRNA-126-3p inhibits pancreatic cancer development by targeting ADAM9. Mol Ther Nucleic Acids, 16, 229\u2013245.","journal-title":"Mol Ther Nucleic Acids"},{"key":"9995_CR138","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017). Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacologica Sinica, 38, 754\u2013763.","journal-title":"Acta Pharmacologica Sinica"},{"key":"9995_CR139","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy, O. M., Nordin, J. Z., Hagey, D. W., de Jong, O. G., Schiffelers, R. M., Andaloussi, S. E., & Vader, P. (2020). Extracellular vesicles as drug delivery systems: Why and how? Advanced Drug Delivery Reviews, 159, 332\u2013343.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"9995_CR140","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.2147\/DDDT.S265423","volume":"14","author":"L Zuo","year":"2020","unstructured":"Zuo, L., Tao, H., Xu, H., Li, C., Qiao, G., Guo, M., Cao, S., Liu, M., & Lin, X. (2020). Exosomes-coated miR-34a displays potent antitumor activity in pancreatic cancer both in vitro and in vivo. Drug Des Devel Ther, 14, 3495\u20133507.","journal-title":"Drug Des Devel Ther"},{"key":"9995_CR141","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1158\/1940-6207.CAPR-20-0053","volume":"13","author":"NJ Chu","year":"2020","unstructured":"Chu, N. J., Anders, R. A., Fertig, E. J., Cao, M., Hopkins, A. C., Keenan, B. P., Popovic, A., Armstrong, T. D., Jaffee, E. M., & Zimmerman, J. W. (2020). Inhibition of miR-21 regulates mutant KRAS effector pathways and intercepts pancreatic ductal adenocarcinoma development. Cancer Prevention Research (Philadelphia, Pa.), 13, 569\u2013582.","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"key":"9995_CR142","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1158\/1078-0432.CCR-17-2733","volume":"24","author":"ME Gilles","year":"2018","unstructured":"Gilles, M. E., Hao, L., Huang, L., Rupaimoole, R., Lopez-Casas, P. P., Pulver, E., Jeong, J. C., Muthuswamy, S. K., Hidalgo, M., Bhatia, S. N., & Slack, F. J. (2018). Personalized RNA Medicine for Pancreatic Cancer. Clinical Cancer Research, 24, 1734\u20131747.","journal-title":"Clinical Cancer Research"},{"key":"9995_CR143","first-page":"927","volume":"34","author":"X Fei","year":"2020","unstructured":"Fei, X., Jin, H. Y., Gao, Y., Kong, L. M., & Tan, X. D. (2020). Hsa-miR-10a-5p promotes pancreatic cancer growth by BDNF\/SEMA4C pathway. Journal of Biological Regulators and Homeostatic Agents, 34, 927\u2013934.","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"key":"9995_CR144","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/gutjnl-2018-316627","volume":"68","author":"F Kong","year":"2019","unstructured":"Kong, F., Li, L., Wang, G., Deng, X., Li, Z., & Kong, X. (2019). VDR signaling inhibits cancer-associated-fibroblasts\u2019 release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells. Gut, 68, 950\u2013951.","journal-title":"Gut"},{"key":"9995_CR145","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13046-018-0739-x","volume":"37","author":"G Xiong","year":"2018","unstructured":"Xiong, G., Huang, H., Feng, M., Yang, G., Zheng, S., You, L., Zheng, L., Hu, Y., Zhang, T., & Zhao, Y. (2018). MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research, 37, 76.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9995_CR146","first-page":"1674","volume":"8","author":"P Sheedy","year":"2018","unstructured":"Sheedy, P., & Medarova, Z. (2018). The fundamental role of miR-10b in metastatic cancer. American Journal of Cancer Research, 8, 1674\u20131688.","journal-title":"American Journal of Cancer Research"},{"key":"9995_CR147","doi-asserted-by":"crossref","first-page":"e23442","DOI":"10.1002\/jcla.23442","volume":"34","author":"C Xu","year":"2020","unstructured":"Xu, C., & Qi, X. (2020). MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7. J Clin Lab Anal, 34, e23442.","journal-title":"J Clin Lab Anal"},{"key":"9995_CR148","doi-asserted-by":"publisher","first-page":"e0201046","DOI":"10.1371\/journal.pone.0201046","volume":"13","author":"B Yoo","year":"2018","unstructured":"Yoo, B., Greninger, P., Stein, G. T., Egan, R. K., McClanaghan, J., Moore, A., Benes, C. H., & Medarova, Z. (2018). Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin. PLoS One, 13, e0201046.","journal-title":"PLoS One"},{"key":"9995_CR149","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/s41598-019-41251-9","volume":"9","author":"B Yoo","year":"2019","unstructured":"Yoo, B., Jordan, V. C., Sheedy, P., Billig, A. M., Ross, A., Pantazopoulos, P., & Medarova, Z. (2019). RNAi-mediated PD-L1 inhibition for pancreatic cancer immunotherapy. Science and Reports, 9, 4712.","journal-title":"Science and Reports"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-021-09995-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T18:45:05Z","timestamp":1699555505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-021-09995-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9995"],"URL":"https:\/\/doi.org\/10.1007\/s10555-021-09995-x","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}